Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. Oct-Dec 2017;38(4):434-439.
doi: 10.4103/ijmpo.ijmpo_168_16.

Metabolic Syndrome and Breast Cancer Risk

Free PMC article

Metabolic Syndrome and Breast Cancer Risk

Burhan Wani et al. Indian J Med Paediatr Oncol. .
Free PMC article


Objective: The study was meant to estimate the prevalence of metabolic syndrome in patients with breast cancer and to establish its role as an independent risk factor on occurrence of breast cancer.

Materials and methods: Fifty women aged between 40 and 80 years with breast cancer and fifty controls of similar age were assessed for metabolic syndrome prevalence and breast cancer risk factors, including age at menarche, reproductive status, live births, breastfeeding, and family history of breast cancer, age at diagnosis of breast cancer, body mass index, and metabolic syndrome parameters.

Results: Metabolic syndrome prevalence was found in 40.0% of breast cancer patients, and 18.0% of those in control group (P = 0.02). An independent and positive association was seen between metabolic syndrome and breast cancer risk (odds ratio = 3.037; 95% confidence interval 1.214-7.597).

Conclusions: Metabolic syndrome is more prevalent in breast cancer patients and is an independent risk factor for breast cancer.

Keywords: Breast cancer; metabolic syndrome; risk factor.

Conflict of interest statement

There are no conflicts of interest.

Similar articles

See all similar articles

Cited by 3 articles


    1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53. - PubMed
    1. Sathyaprakash R, Henry RR. Preventing diabetes by treating aspects of the metabolic syndrome. Curr Diab Rep. 2002;2:416–22. - PubMed
    1. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Third National Health and Nutrition Examination Survey (NHANES III), National Cholesterol Education Program (NCEP), et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52:1210–4. - PubMed
    1. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: A review of the current evidence. Am J Clin Nutr. 2007;86:s823–35. - PubMed
    1. Vona-Davis L, Howard-McNatt M, Rose DP. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev. 2007;8:395–408. - PubMed